129 related articles for article (PubMed ID: 19990809)
1. A Case of Polycythæmia Vera in which Phenyl hydrazine Treatment was followed by Acute Platelet Reactions.
Hare DC
Proc R Soc Med; 1936 Aug; 29(10):1222-3. PubMed ID: 19990809
[No Abstract] [Full Text] [Related]
2. Qualitative platelet defect and thrombohaemorrhagic complications in a patient with polycythaemia vera. Case 10.
Friess D; Lämmle B; Alberio L
Hamostaseologie; 2003 Aug; 23(3):138-43. PubMed ID: 12923585
[TBL] [Abstract][Full Text] [Related]
3. Spinal subarachnoid haematoma after neuraxial anaesthesia in a patient with polycythaemia vera.
Martins T; Montenegro L; Silva A; Reis H; Pereira E; Lucas P
Anaesth Rep; 2021; 9(1):8-11. PubMed ID: 33479701
[TBL] [Abstract][Full Text] [Related]
4. Antiplatelet drugs for polycythaemia vera and essential thrombocythaemia.
Squizzato A; Romualdi E; Middeldorp S
Cochrane Database Syst Rev; 2008 Apr; (2):CD006503. PubMed ID: 18425953
[TBL] [Abstract][Full Text] [Related]
5. Recurrent ischaemic stroke unveils polycythaemia vera.
Abdel-Rahman I; Murphy C
BMJ Case Rep; 2015 Mar; 2015():. PubMed ID: 25754163
[TBL] [Abstract][Full Text] [Related]
6. Increased platelet thrombus formation under flow conditions in whole blood from polycythaemia vera patients.
Vignoli A; Gamba S; van der Meijden PEJ; Marchetti M; Russo L; Tessarolo S; Giaccherini C; Swieringa F; Ten Cate H; Finazzi G; Heemskerk JWM; Falanga A
Blood Transfus; 2022 Mar; 20(2):143-151. PubMed ID: 33819141
[TBL] [Abstract][Full Text] [Related]
7. Antiplatelet drugs for polycythaemia vera and essential thrombocythaemia.
Squizzato A; Romualdi E; Passamonti F; Middeldorp S
Cochrane Database Syst Rev; 2013 Apr; (4):CD006503. PubMed ID: 23633335
[TBL] [Abstract][Full Text] [Related]
8. Long-term efficacy and safety of ruxolitinib versus best available therapy in polycythaemia vera (RESPONSE): 5-year follow up of a phase 3 study.
Kiladjian JJ; Zachee P; Hino M; Pane F; Masszi T; Harrison CN; Mesa R; Miller CB; Passamonti F; Durrant S; Griesshammer M; Kirito K; Besses C; Moiraghi B; Rumi E; Rosti V; Blau IW; Francillard N; Dong T; Wroclawska M; Vannucchi AM; Verstovsek S
Lancet Haematol; 2020 Mar; 7(3):e226-e237. PubMed ID: 31982039
[TBL] [Abstract][Full Text] [Related]
9. Polycythaemia rubra vera transforming to acute lymphoblastic leukaemia with a common immunophenotype.
Neilson JR; Patton WN; Williams MD; Mayne EE; Boughton BJ
J Clin Pathol; 1994 May; 47(5):471-2. PubMed ID: 8027406
[TBL] [Abstract][Full Text] [Related]
10. Laparoscopic hepatectomy in a patient with uncontrolled polycythaemia vera.
Riekki TR; Ling E; Cordovani D
Anaesth Rep; 2019; 7(2):92-95. PubMed ID: 32051960
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiology and treatment of platelet-mediated microvascular disturbances, major thrombosis and bleeding complications in essential thrombocythaemia and polycythaemia vera.
Michiels JJ; Berneman ZN; Schroyens W; Van Vliet HH
Platelets; 2004 Mar; 15(2):67-84. PubMed ID: 15154599
[TBL] [Abstract][Full Text] [Related]
12. Hydroxycarbamide associated platelet count oscillations in a patient with polycythaemia vera. A case report and review of the literature.
Burthem J; Chaudhry MS
Platelets; 2008 May; 19(3):234-5. PubMed ID: 18432524
[TBL] [Abstract][Full Text] [Related]
13. Management of polycythaemia vera, essential thrombocythaemia and myelofibrosis with hydroxyurea.
Löfvenberg E; Wahlin A
Eur J Haematol; 1988 Oct; 41(4):375-81. PubMed ID: 3197824
[TBL] [Abstract][Full Text] [Related]
14. Serum erythropoietin in the diagnosis of polycythaemia and after phlebotomy treatment.
Birgegård G; Wide L
Br J Haematol; 1992 Aug; 81(4):603-6. PubMed ID: 1390249
[TBL] [Abstract][Full Text] [Related]
15. Polycythaemia and portal vein thrombosis.
Drénou B; Le Prisé PY; Poilane B; Bernard-Griffiths I; Ghandour C; Fauchet R
Nouv Rev Fr Hematol (1978); 1992; 34(5):399-403. PubMed ID: 1296193
[TBL] [Abstract][Full Text] [Related]
16. Polycythaemia Vera Presenting As A Porta Hepatis Mass.
Ahmed S; Irfan O; Siddique S; Abid S
J Ayub Med Coll Abbottabad; 2019; 31(4):627-628. PubMed ID: 31933324
[TBL] [Abstract][Full Text] [Related]
17. Thrombocytosis, thrombocythaemia and iron deficiency in patients with polycythaemia vera.
Shaw D; Tudhope GR
Acta Haematol; 1979; 62(4):223-8. PubMed ID: 119415
[TBL] [Abstract][Full Text] [Related]
18. The polycythaemia rubra vera-1 gene is constitutively expressed by bone marrow cells and does not discriminate polycythaemia vera from reactive and other chronic myeloproliferative disorders.
Bock O; Serinsöz E; Neusch M; Schlué J; Kreipe H
Br J Haematol; 2003 Nov; 123(3):472-4. PubMed ID: 14617008
[TBL] [Abstract][Full Text] [Related]
19. Symptom burden and quality of life in patients with high-risk essential thrombocythaemia and polycythaemia vera receiving hydroxyurea or pegylated interferon alfa-2a: a post-hoc analysis of the MPN-RC 111 and 112 trials.
Mazza GL; Mead-Harvey C; Mascarenhas J; Yacoub A; Kosiorek HE; Hoffman R; Dueck AC; Mesa RA;
Lancet Haematol; 2022 Jan; 9(1):e38-e48. PubMed ID: 34971581
[TBL] [Abstract][Full Text] [Related]
20. Proliferating cell nuclear antigen expression by erythroid precursors in normal bone marrow, in reactive lesions and in polycythaemia rubra vera.
Thiele J; Meuter RB; Titius RB; Zankovich R; Fischer R
Histopathology; 1993 May; 22(5):429-35. PubMed ID: 8102113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
